MedPath

Advancing Student Suicide Interventions With Scalable Technologies

Not Applicable
Not yet recruiting
Conditions
Suicidal Ideation
Suicide Attempt
Self-Harm
Registration Number
NCT07211373
Lead Sponsor
University of Massachusetts, Amherst
Brief Summary

Mobile-based applications, such as JasprHealth, can deliver evidence-based skills intended to reduce imminent suicide risk (e.g., reducing means access), improve emotional states (e.g., via distraction and coaching to act opposite to emotions), and reduce feelings of social isolation (e.g., via shared stories), but user engagement is a barrier. The aim of this study was to examine the effects of a technological application resource (Jaspr) relative to human augmentation (Jaspr+, e.g., motivationally focused orientation plus prompts) on acceptability, preliminary effectiveness, and engagement among college students who screen positive for suicide risk.

Detailed Description

Mobile-based applications, such as Jaspr Health, can deliver evidence-based skills intended to reduce imminent suicide risk (e.g., reducing means access), improve emotional states (e.g., via distraction and coaching to act opposite to emotions), and reduce feelings of social isolation (e.g., via shared stories). Although mobile-device-delivered interventions hold the potential to make interventions widely accessible, user engagement presents a substantial barrier to efficacy.(Toritsemogba Tosanbami Omaghomi et al., 2023; Torous et al., 2018) This study, ASSIST: Advancing Student Suicide Interventions with Scalable Technologies, aims to improve engagement with mobile-delivered suicide prevention applications, with the ultimate goal of reducing suicidal thoughts and behaviors in college students. Including human elements alongside Jaspr Health has the potential to improve the uptake of this evidence-based, accessible mobile-device-delivered intervention.(Blankers et al., 2011; Gellatly et al., 2007)

The aim of this study was is to examine the effects of the technological application resource Jaspr tablet application with access to Jaspr at Home (JAH) vs. Jaspr+ human augmentation (e.g., motivationally focused orientation plus prompts) on acceptability, preliminary effectiveness, and engagement among 50 college students who screen positive for suicide risk (n=25 per condition) over the course of 2 months. Candidate mechanisms (e.g., coping skills, self-stigma) will also be assessed. Participants were randomized via the Redcap randomization module (Harris et al., 2019), stratified by site.

Recruitment & Eligibility

Status
NOT_YET_RECRUITING
Sex
All
Target Recruitment
50
Inclusion Criteria
  • Recent suicidal thoughts or behavior (i.e., past 2-week suicidal ideation or past 6-month suicidal behaviors)
  • Current UMass Amherst or University of Wisconsin Madison undergraduate student
  • 18 years of age or older
  • Ability to understand written or spoken English
  • Owning a mobile device
  • Ability to understand and consent to study procedures
Exclusion Criteria
  • No recent suicidal thoughts or behaviors (i.e., past 2-week suicidal ideation or past 6-month suicidal behaviors)
  • Not a current UMass Amherst or University of Wisconsin Madison undergraduate student
  • Under 18 years of age
  • Inability to understand written or spoken English
  • Does not own a mobile device

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Suicidal ideationweeks 0, 4, 8

Assessed with Suicide Ideation Questionnaire \[SIQ, (Reynolds, 1987)\], with higher scores reflecting greater past month suicidal ideation.

Suicidal behaviorsweeks 0, 1, 2, 3, 4, 8

Assessed with the Columbia-Suicide Severity Rating Scale \[C-SSRS (Posner, 2008)\] self-report screen past week (y/n)

Secondary Outcome Measures
NameTimeMethod
Suicide-related copingweeks 0, 4, 8

Assessed with the suicide-related coping scale, \[SRCS, (Stanley et al., 2017)\] with higher scores reflecting a better ability to cope with suicidal thoughts

Ways of copingweeks 0, 4, 8

Assessed with the DBT-Ways of Coping Checklist (DBT-WCCL (Neacsiu et al., 2010)), which yields scales of skills use, general dysfunctional coping, and blaming others, with mean scores of 0-3, with higher levels indicating greater use of those strategies.

Suicide stigmaweeks 0, 4, 8

Assessed with the personal suicide stigma questionnaire \[PSSQ, (Maclean et al., 2023)\], with higher scores reflecting greater stigma.

Self-reported engagementweeks 0, 1, 2, 3, 4, 8

Assessed with item developed for this study, with higher scores reflecting greater engagement in the app.

Acceptabilityweeks 0, 4, 8

Assessed with the Acceptability of Implementation Measure \[AIM, (Weiner et al., 2017)\], with higher scores reflecting whether the intervention is liked, welcomed, or approved.

Satisfaction with Interventionweeks 0, 4, 8

Assessed with the Client Satisfaction Questionnaire - 8 \[CSQ8, (Attkisson \& Greenfield, 2004; Kelly et al., 2018; Larsen et al., 1979)\], with higher scores reflecting greater satisfaction with the intervention.

Trial Locations

Locations (1)

University of Massachusetts Amherst

🇺🇸

Amherst, Massachusetts, United States

University of Massachusetts Amherst
🇺🇸Amherst, Massachusetts, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.